– Soil Grid Program Confirms 7km Trend Across Rakounga Concession

– Extends Mineralized Footprint Between Koaltenga and Pelatanga Gold Zones

VANCOUVER, BC / ACCESSWIRE / August 30, 2018 / Nexus Gold Corp. (“Nexus” or the “Company”) (TSX-V: NXS, OTC: NXXGF, FSE: N6E) is pleased to report that it has received results from its recently completed 105-line kilometer soil sampling survey conducted on the Rakounga exploration permit located 109 kilometers north west of the capital city of Ouagadougou, in Burkina Faso, West Africa.

The survey was designed to investigate the gold bearing potential on the permit ground occurring between the Koaltenga gold zone, located near the western boundary of the Rakounga concession, and Pelatanga-Rawema gold trend, on the Company’s adjacent Bouboulou exploration permit (see figure 1).

Results from the survey successfully identified an anomalous gold trend which extends for approximately 7,000 meters (seven kilometers) along the southwest-northeast axis and broadens to widths of 2,500 meters. The newly identified 7,000-meter gold trend at Rakounga aligns with the 5km Pelatanga-Rawema (“PR”) trend previously identified on the adjacent Bouboulou concession, indicating the mineralized footprint at the combined Bouboulou-Rakounga concessions now exceeds 15km in length.

“The goal of the soil grid program was to establish continuity of the gold trends at Bouboulou onto the adjacent Rakounga concession,” said
president & CEO, Alex Klenman. “The results indicate a sizeable trend extends from the northeast of Bouboulou to
the southwest of Rakounga. We’re pleased with the results, that’s a big footprint, and suggestive of the potential at Rakounga,”
continued Mr. Klenman.

“It is impressive how the geochemical data highlights the gold trend coming off the Bouboulou ground,” said Senior Vice-President of Exploration, Warren Robb. “We will combine this data with the regional geophysics data to identify any coincidental anomalies, and then look to test those anomalies along the trends,” continued Mr. Robb.

Prior drilling by the Company at Koala, along the northeastern part of the trend, returned several intercepts of note, including 5.21 grams-per-tonne (“g/t”) gold (“Au”) over 3.05 meters, including 15.50 g/t Au over 1 meter (hole BBL-17-DD-07), and 4.41 g/t Au over 8.15 meters, including 23 g/t Au over 1 meter (hole BBL-17-DD-08) (see Company news release dated October 5, 2017).

Previous drilling conducted by the Company at Koaltenga, at the southwestern extension of the trend, returned significant results including 1.01 g/t over 32 meters (including 5.65 g/t Au over 2 meters and 2.81 g/t Au over 6 meters in hole RKG-17-RC-002) and 1.00 g/t gold over 34 meters (including 5.57 g/t Au over 4 meters in hole RKG-17-RC-008) (see Company news release of December 13, 2017).

The survey covered an area underlain by the Sabce fault zone, a prominent structural feature which extends some 200 kilometers across the Goren greenstone belt.

Figure 1: Newly confirmed PR Trend extension at the Rakounga gold
concession, Burkina Faso

The 105-line kilometer geochemical soil survey included line spacing of 400 meters with samples collected at stations established along the lines at intervals of 50 meters. A total of 1,960 samples were submitted to ACTLABS for analysis at their laboratories in Ouagadougou, Burkina Faso. The soil samples were analyzed utilizing the Au Cyanidation Atomic Absorption method. In addition to the laboratories internal QA/QC procedures the Company maintained its own QA/QC protocol of inserting standards, blanks and duplicates into the sampling stream.

About the Company

Nexus Gold is a Vancouver-based gold exploration and development company operating primarily in Burkina Faso, West Africa. The company is currently concentrating its efforts on establishing a compliant resource at one or more of it’s three current projects. The 38-square km Bouboulou project comprises no less than five established gold zones contained within three separate 5km gold trends. The adjacent 250-square km Rakounga gold concession extends the Bouboulou gold trends and currently contains three drill tested zones of mineralization. The Niangouela gold concession is a 178-square km project featuring high-grade gold occurring in and around a primary quartz vein and associated shear zone approximately one km in length.

Warren Robb P.Geo., Vice-President,
Exploration, is the designated Qualified Person as defined by National
Instrument 43-101 and is responsible for the technical information contained in
this release.

On behalf of the Board of Directors of

NEXUS GOLD CORP.

Alex Klenman

President & CEO

604-558-1920
info@nexusgoldcorp.com
www.nexusgoldcorp.com

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. This news release may contain forward-looking statements. These statements are based on current expectations and assumptions that are subject to risks and uncertainties. Actual results could differ materially because of factors discussed in the management discussion and analysis section of our interim and most recent annual financial statement or other reports and filings with the TSX Venture Exchange and applicable Canadian securities regulations. We do not assume any obligation to update any forward-looking statements, except as required by applicable laws.

SOURCE: Nexus Gold Corp.

ReleaseID: 511026

IRVINE, CA / ACCESSWIRE / August 30, 2018 / PRO-DEX, INC. (NASDAQ: PDEX) today announced financial results for its fiscal 2018 fourth quarter and full-year ended June 30, 2018.

Quarter Ended June 30, 2018

Net sales for the three months ended June 30, 2018 increased $650,000, or 12%, to $6.2 million from $5.6 million for the three months ended June 30, 2017, due primarily to increased medical device sales to our largest customer of a product used in orthopedic surgical applications. Gross profit for the three months ended June 30, 2018 increased $398,000, or 20%, to $2.4 million from $2.0 million for the same period in 2017. The increase in gross margin is due to better absorption of our fixed costs due to higher sales volumes, as well as manufacturing efficiencies derived this fiscal year from higher volumes and continued investment in new machinery.

Operating expenses (which include selling, general and administrative, and research and development expenses) for the quarter ended June 30, 2018 increased 59% to $1.9 million from $1.2 million in the prior year’s corresponding quarter, reflecting the impairment of our entire $800,000 investment in Monogram Orthopaedics Inc. (“Monogram”). While we do not expect to recover our investment, all of our contractual rights related to Monogram remain intact and we remain hopeful that Monogram will ultimately meet its capital funding requirements and reach production stage so that we may eventually monetize our contractual right to manufacture certain of its products.

Income from continuing operations for the quarter ended June 30, 2018 decreased by $550,000, to $168,000, compared to $718,000 in the corresponding quarter in 2017. Net income for the quarter ended June 30, 2018 was $168,000, or $0.04 per share, a decrease of 77%, compared to net income of $716,000, or $0.18 per share, for the corresponding quarter in 2017. Excluding the impact of the Monogram impairment discussed above adjusted net income would be $968,000, or $0.22 per diluted share, for the quarter ended June 30, 2018.

Year Ended June 30, 2018

Net sales for the fiscal year ended June 30, 2018 increased $522,000, or 2%, to $22.5 million from $21.9 million for the fiscal year ended June 30, 2017, due primarily to increases in medical device revenues. Specifically, our largest customer accounted for an increase of $1.6 million in revenue during fiscal 2018. Offsetting this increase, sales to one of our CMF customers decreased by approximately $1.1 million, from $1.4 million in fiscal 2017 to $253,000 in fiscal 2018. We anticipate that we will enter into a new development agreement with this customer to make the next generation of their CMF driver; however, we are still in negotiations.

Gross profit for the fiscal year ended June 30, 2018 increased $757,000, or 11%, to $7.9 million compared to $7.2 million for fiscal 2017, due to increased revenues and manufacturing efficiencies.

Operating expenses (which include selling, general and administrative, and research and development expenses) for the fiscal year ended June 30, 2018 increased 25% to $5.6 million from $4.5 million in the prior fiscal year, reflecting impairment charges related to our Monogram investment as well as our Fineline Molds division, which we sold in May 2018.

Income from continuing operations before income taxes for the fiscal year ended June 30, 2018 was $2.6 million compared to $2.8 million for fiscal 2017. During fiscal 2017, we eliminated the valuation allowance against our deferred tax asset, after having achieved cumulative earnings over a three year look back period, which is the primary contributor to the $2.1 million tax benefit recorded in fiscal 2017. Net income for the fiscal year ended June 30, 2018 was $1.6 million, or $0.37 per share, compared to $5.1 million, or $1.25 per share, for fiscal 2017. Excluding the impact of the Monogram impairment discussed above adjusted net income would be $2.4 million, or $0.56 per diluted share, for the year ended June 30, 2018.

Although the Company has released its earnings prior to the filing of its annual Form 10-K with the Securities and Exchange Commission, we are able to do this because we are a smaller reporting company and we have more time to do so at fiscal year-end. During our quarterly reporting periods we anticipate that our earnings releases will continue to be released at the same time as our Form 10-Q’s are filed with the Securities and Exchange Commission. We anticipate filing our Form 10-K with the Securities and Exchange Commission on September 13, 2018.

CEO Comments

Richard L. (“Rick”) Van Kirk, the Company’s President and Chief Executive Officer, commented, “We are pleased with our fiscal 2018 results, especially our higher sales volumes and improved margins. In addition to ramping up manufacturing volumes for our largest customer in fiscal 2018, we recently completed the development of our thoracic driver and entered a supply agreement with one of our existing customers to private-label the product. We anticipate sales of the driver and accessories to begin in late fiscal 2019.”

About Pro-Dex, Inc.:

Pro-Dex, Inc. specializes in the design, development, and manufacture of autoclavable, battery-powered, and electric multi-function surgical drivers and shavers used primarily in the orthopedic, spine, and maxocranial facial markets. We have patented adoptive torque-limiting software and proprietary sealing solutions which appeal to our customers, primarily medical device distributors. Pro-Dex also sells rotary air motors. Pro-Dex’s products are found in hospitals and medical engineering labs around the world. For more information, visit the Company’s website at www.pro-dex.com.

Statements herein concerning the Company’s plans, growth and strategies may include ”forward-looking statements” within the context of the federal securities laws. Statements regarding the Company’s future events, developments and future performance, as well as management’s expectations, beliefs, plans, estimates, or projections relating to the future are forward-looking statements within the meaning of these laws. The Company’s actual results may differ materially from those suggested as a result of various factors. Interested parties should refer to the disclosure concerning the operational and business concerns of the Company set forth in the Company’s filings with the Securities and Exchange Commission.

CONTACT:

Richard L. Van Kirk, Chief Executive Officer
(949) 769-3200

PRO-DEX, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(In thousands, except share data)

June 30,

2018

2017

ASSETS

Current assets:

Cash and cash equivalents

$
5,188

$
4,205

Investments

2,220

718

Accounts receivable, net of allowance for doubtful accounts of $14 and $3 at June 30, 2018 and 2017, respectively

2,955

3,538

Deferred costs

32

12

Assets held for sale

–

363

Notes receivable

1,176

–

Inventory

4,393

3,084

Prepaid expenses and other current assets

269

363

Total current assets

16,233

12,283

Plant, equipment and leasehold improvements, net

1,755

1,350

Intangibles, net

140

149

Deferred income taxes, net

1,678

2,048

Notes receivable, net of current portion

43

450

Other assets

68

71

Total assets

$
19,917

$
16,351

LIABILITIES AND SHAREHOLDERS’ EQUITY

Current liabilities:

Accounts payable

$
1,083

$
1,159

Accrued liabilities

1,266

1,344

Deferred revenue

31

19

Income taxes payable

123

–

Note payable

–

26

Capital lease obligations

35

32

Total current liabilities

2,538

2,580

Non-current liabilities:

Deferred rent

97

–

Capital leases payable, net of current portion

6

61

Total non-current liabilities

103

61

Total liabilities

2,641

2,641

Commitments and Contingencies:

Shareholders’ equity:

Common stock, no par value, 50,000,000 shares authorized; 4,331,089 and 4,025,193 shares issued and outstanding at June 30, 2018 and 2017, respectively

19,835

17,704

Accumulated other comprehensive income

(153
)

33

Accumulated deficit

(2,406
)

(4,027
)

Total shareholders’ equity

17,276

13,710

Total liabilities and shareholders’ equity

$
19,917

$
16,351

PRO-DEX, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data)

Three Months Ended

June 30,

(Unaudited)

Years Ended

June 30,

2018

2017

2018

2017

Net sales

$
6,247

$
5,597

$
22,465

$
21,943

Cost of sales

3,858

3,606

14,522

14,757

Gross profit

2,389

1,991

7,943

7,186

Operating (income) expenses:

Selling expenses

101

146

358

585

General and administrative expenses

506

635

2,287

2,529

Asset impairment charges

800

–

1,029

113

Gain from disposal of equipment

–

–

(16
)

(3
)

Research and development costs

448

386

1,893

1,225

Total operating expenses

1,855

1,167

5,551

4,449

Operating profit

534

824

2,392

2,737

Interest expense

(1
)

(2
)

(7
)

(12
)

Interest and dividend income

59

8

225

27

Income from continuing operations before income taxes

592

830

2,610

2,752

Income tax expense (benefit)

424

112

989

(2,089
)

Income from continuing operations

168

718

1,621

4,841

Income (loss) from discontinued operations, net of income taxes

–

(2
)

–

243

Net income

$
168

$
716

$
1,621

$
5,084

Basic net income per share:

Income from continuing operations

$
0.04

$
0.18

$
0.38

$
1.20

Income from discontinued operations

–

–

–

0.06

Net income

$
0.04

$
0.18

$
0.38

$
1.26

Diluted net income per share:

Income from continuing operations

$
0.04

$
0.18

$
0.37

$
1.19

Income from discontinued operations

–

–

–

0.06

Net income

$
0.04

$
0.18

$
0.37

$
1.25

Weighted average shares outstanding:

Basic

4,349,487

4,020,415

4,304,602

4,040,308

Diluted

4,389,268

4,057,117

4,344,765

4,077,575

PRO-DEX, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)

Years Ended June 30,

2018

2017

CASH FLOWS FROM OPERATING ACTIVITIES:

Net income

$
1,621

$
5,084

Adjustments to reconcile net income to net cash provided by operating activities:

Depreciation and amortization

557

555

Gain on sale of OMS

–

(327
)

Gain on sale or disposal of equipment

(16
)

(3
)

Asset impairment charges

1,029

113

Share-based compensation

194

3

Deferred income taxes

391

(2,048
)

Bad debt expense (recovery)

14

(17
)

Changes in operating assets and liabilities:

Accounts receivable, due from factor and other current receivables

569

(633
)

Deferred costs

(19
)

226

Assets held for sale

31

(22
)

Inventory

(1,309
)

279

Prepaid expenses and other assets

(45
)

(299
)

Accounts payable, accrued expenses and deferred rent

(57
)

518

Deferred revenue

13

(193
)

Income taxes payable

123

(1
)

Net cash provided by operating activities

3,096

3,235

CASH FLOWS FROM INVESTING ACTIVITIES:

Purchases of equipment and leasehold improvements

(923
)

(606
)

Proceeds from sale of OMS

–

636

Purchase of notes receivable

(350
)

(450
)

Investment in Loan Participation

(1,150
)

–

Proceeds from sale of investment in Ramsey

–

86

Proceeds from sale of equipment

30

3

Increase in intangibles

(11
)

(32
)

Purchase of investments

(1,711
)

(663
)

Net cash used in investing activities

(4,115
)

(1,026
)

CASH FLOWS FROM FINANCING ACTIVITIES:

Principal payments on capital lease and note payable

(78
)

(59
)

Proceeds from shares issued under ATM

2,262

48

Borrowings from Summit loan

–

600

Repayments on Summit loan

–

(600
)

Repurchases of common stock

(220
)

(312
)

Proceeds from exercise of stock options and ESPP contributions

38

25

Net cash provided by (used in) financing activities

2,002

(298
)

Net increase in cash and cash equivalents

983

1,911

Cash and cash equivalents, beginning of year

4,205

2,294

Cash and cash equivalents, end of year

$
5,188

$
4,205

Supplemental Information – Reconciliation of GAAP to Non-GAAP Financial Measures

We have supplemented the reporting of our financial information determined under accounting principles generally accepted in the United States (“GAAP”) with certain non-GAAP financial measures, including adjusted net income and adjusted net income per diluted share. We believe that these non-GAAP measures provide meaningful information to assist investors and shareholders in understanding our financial results and assessing our prospects for future performance. Management believes adjusted net income is an important indicator of our operations because it excludes the Monogram impairment charge which is a non-routine one-time charge, which had no tax benefit in the period it was recorded.

The following reconciles the GAAP financial measures to the non-GAAP financial measures discussed above.

Reconciliation of Non-GAAP Financial Measures

For the three

months ended

June 30,

2018

For the Year

ended

June 30,

2018

(In thousands, except share data)

Net Income

$
168

$
1,621

Monogram impairment, net of tax of $0

$
800

$
800

Adjusted Net Income

$
968

$
2,421

Weighted average shares outstanding:

Diluted

4,389,268

4,304,602

Diluted net income per share:

Net Income

$
0.04

$
0.37

Adjusted Net Income

$
0.22

$
0.56

SOURCE: PRO-DEX, Inc.

ReleaseID: 510934

– Adjusted EBITDA up 6.6% and Adj. EBITDA margin expanded 81bps reflecting improved profitability in Argentina, Brazil and Peru, along with efficiency initiatives across the organization
– Increase in operating results did not entirely flow through to bottom line as net profit was impacted by a non-cash FX loss due to the CLP devaluation against USD, partially offset by lower tax expenses
– The online channel of the retail businesses posted a 54% increase compared to 2Q17
– Net Financial Debt / Adj. EBITDA ratio stood at 3.99x

SANTIAGO, CHILE / ACCESSWIRE / August 30, 2018 / Cencosud S.A. (BCS: CENCOSUD), a leading South American retailer with operations in Chile, Argentina, Brazil, Peru and Colombia, today announced its consolidated financial results for the second quarter of 2018. All figures are in Chilean pesos (CLP), except where indicated otherwise, and in accordance with IFRS.

Revenues decreased 6.9% in comparison to 2Q17 impacted by currency depreciation against the CLP in all countries the Company operates and food deflation in Brazil and Peru. At a constant exchange rate, revenues increased 8.3% explained mainly by the improved performance of Argentina, Peru, Chile and Brazil. The operational highlights were Supermarkets Brazil and Peru, which achieved Same Store Sales (SSS) above inflation, together with Home Improvement across all countries of operation which posted sales increase above inflation, as well as Department Stores in Peru.
Adjusted EBITDA increased 6.6% YoY (+22.4% at constant exchange rate) reaching CLP 153,241 million and margin expanded 81 basis points (bps) driven by the improved profitability in Argentina, Brazil and Peru. Argentina achieved higher profitability in Home Improvement and Financial Services. Peru achieved higher profitability in most of its business units.
Net Profit for the period was CLP 3,682 million, a decrease of CLP 20,364 million YoY explained by a decline in the income from foreign exchange variations (CLP 47,223 million) and a lower asset revaluation (CLP 12,689 million) partially offset by the higher profitability from the businesses (+CLP 13,570 million) and lower tax expenses.
Net Debt to Adjusted EBITDA stood at 3.99x.

Please visit www.investors.cencosud.com to obtain the complete fourth quarter earnings release, including financial results and tables.

Management Comment

We are continuing to see the benefits from successfully executing our strategic pillars. However, the macro environment across the region, particularly with respect to currency, became more challenging as we moved through the quarter. By contrast, we had the positive benefit from the Soccer World Cup. Taking all of these events into account, we saw positive same store sales trends for Supermarkets, Home Improvement and Department stores in many of the countries in which we operate.

We are particularly pleased with the growth we are seeing with e-commerce as consumers are responding favorably to this channel with sales increasing 54% in the quarter. We have also been implementing cost saving initiatives, which are key to continue delivering higher profitability. As a result of this we saw an increase in Adjusted EBITDA of 6.6% and 81 bps margin expansion.

In summary, we continue to focus on strengthening and differentiating our product offering, getting better and more efficient with marketing and promotions, building our omni-channel business, and expanding what has proven to be a very successful retail model. Our relentless focus on cost savings initiatives is showing positive results and we remain committed to carefully managing our expenses in order to drive efficiencies in the business and improve profitability.

Conference Call

The Company will host a conference call to discuss these results on Friday, August 31, 2018 at 12:00PM Chilean time/ 11:00AM EST. To participate on the day of the call, dial (1-877) 407 8133 or (1201) 689 8040 approximately ten minutes before the call and tell the operator you wish to join the Cencosud Conference Call. A webcast of the conference call will be available online at http://investors.cencosud.com/English/investor-overview/financials/quarterly-reports/default.aspx

The telephone replay of the conference call will be available until September 7, 2018 at 09:00AM Chilean time/ 08:00AM EST. Callers can access the telephonic replay by dialing (1877)-481-4010 or 1-919-882-2331 and utilizing the passcode 37317 when prompted. Webcast replay will be available until November 24, 2018 at 09:00AM Chilean time/ 08:00AM EST.

Forward-Looking Statements:

In addition to historical information, this release contains “forward-looking statements” that reflect management’s expectations for the future. The forward-looking statements included herein represent Cencosud’s views as of the date of this release. A variety of important factors could cause results to differ materially from such statements. These factors are laid out in Cencosud’s filings with the CMF in Chile. The Company undertakes no obligation to revise or update publicly any forward-looking statement for any reason unless required by law.

Investor Relations

Maria Soledad Fernandez
Phone +5622959 0545
mariasoledad.fernandez@cencosud.cl

Natalia Nacif
Phone +5622959 0368
natalia.nacif@cencosud.cl

Alexandra Kemp
Phone +562 2355 8395
alexandra.kemp@cencosud.cl

SOURCE: Cencosud S.A.

ReleaseID: 511072

NEW YORK, NY / ACCESSWIRE / August 30, 2018 / Deneum, a company aiming to revolutionize the global energy industry with the nuclear fusion Power Station, announced that it has successfully proved the feasibility hypothesis via its laboratory unit during the private demonstration. Deneum also concluded $ 1M during the private round first stage.

Offering global market the Philosopher’s stone of energy generation based on the interaction between Titanium and Deuterium, Deneum has successfully concluded the first private demonstration of the Power Station laboratory unit. The demonstration held in Deneum R&D laboratory in Tallinn implied the Power Station launch and main operating mode showcase. All the indicators including temperature fluctuation, pressure, vacuum density and others were measured and visually represented online via the public proprietary software provided by the independent vendor.

“The main indicator of an appropriate interaction of the active body components within the Deneum Power Station is a successful maintenance of a certain installation mode, in which amount of energy needed for launch, once consumed creates a thin level of resonance that implicates a self-sustaining reaction between titanium hydride and deuterium. This reaction is exothermic with a large amount of excess heat, which is then to some extent converted into electricity and partly used “as is” in the form of thermal energy.

“We were able to achieve and maintain this effect during the demonstration. This makes it 63 successful feasibility tests in a row with this one carefully measured and documented – comments Dmitry Samoylovskikh, Deneum CEO & founder. – We’re witnessing the largest particle physics breakthrough of the century, and Deneum team is very glad to make it happen.”

The reaction produced by the active body components is self-sustaining, which means Power Station keeps on working without any further intervention once launched. Deuterium and Titanium worth $20 installed into the Power Station can maintain a housing area of 100 sq. meters for up to 1 year with no need for recharge or additional service. This is an unprecedented level of energy efficiency beyond what any of the existing sources may offer, including traditional nuclear energy. The energy of Deneum Power Station is yet eco-friendly, renewable and radically cheap.

Deneum team has successfully concluded the first stage of the ICO private round having raised $ 1M. The funding will be re-invested into further R&D and Power Station G3 prototype development as well as the deployment of Deneum own production line manufacturing the Power Station active body main components.

Deneum team is planning to conclude the second stage of the private sale round by the end of September aiming at $ 2M hard cap. The total funding to be raised during all stages of the ICO is estimated at $ 90M.

CONTACT:

Pr@stankeviciusmgm.com

SOURCE: Deneum

ReleaseID: 511073